Images
Participants
Contact
Interview with Teresa Tarragó, co-founder together with Ernest Giralt of the spin-off Iproteos, about the discovery of new drugs for diseases that affect the central nervous system.
Tarragó explains the scope for biotech business opportunities is very big. "The projects have great potential but require a lot of funding. During the valorisation, spin-offs need more support, " says Tarragó. The IRB Barcelona researchers states that in Catalonia there are lots of good ideas but that "if we want more technology transfer we will have to make it carry greater weight when evaluating a researcher’s scientific production."
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
